Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hensen, J.
Right arrow Articles by Gross, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hensen, J.
Right arrow Articles by Gross, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (1996) 11: 622-627
© 1996 European Renal Association-European Dialysis and Transplant Association


research-article

Lithium induced polyuria and renal vasopressin receptor density

Johannes Hensen, Monika Haenelt and Peter Gross

Department of Medicine, Divisions of Endocrinology and Nephrology, Universitäts-Klinikum Steglitz, Freie Universität Berlin Friedrich-Alexander-Universität Erlangen-Nuremberg Med. Klinik I, Germany

Correspondence and offprint requests to: Correspondence and offprint requests to: Johannes Hensen, M.D., Department of Medicine I, Division of Endocrinology and Metabolism, Krankenhausstr, 12, 91054 Erlangen, Germany

BACKGROUND.: Lithium, a drug frequently used for treatment of affective disorders, is known to cause a vasopressin resistant state, leading to polyuria and polydipsia. It has been suggested that lithium interacts with the renal V2-vasopressin receptor. Detailed studies on the influence of lithium on the AVP receptor, however, have so far been difficult due to the lack of a suitable radioligand with high specific activity and high affinity.

METHODS.: Using 125I-[8-(p-(OH)-phenylpropionyl)]-LVP, we studied the effects of lithium on V2-vasopressin receptors in male Sprague-Dawley rats and LLC-PK1 cells. Rats, having free access to water, were orally treated with 10 mg lithium/100 mg b.w./day or placebo for 10 days. Scatchard analysis was performed using membranes prepared from homogenized renal papillae.

RESULTS.: Lithium caused significant polyuria and an impaired renal concentration capacity after water deprivation. Binding studies showed no effect of lithium on binding affinity KD (0.98±0.21 nmol/l vs. 0.86±0.15 nmol/l (Li) (n.s.). Receptor density, however, significantly decreased from 130±12.3 nmol/kg protein in controls (n=8) to 101.7±13.4 nmol/kg protein (n=8), (P<0·05). Plasma osmolality and AVP were not significantly altered by lithium treatment. Vasopressin receptor density on LLC-PK1-cells, a pig renal cell line, was not changed by preincubation with lithium (312±22 nmol/kg vs. 329±25 nmol/kg (Li) (n=6, n.s.).

CONCLUSIONS.: The decrease of AVP-receptor density in vivo might be related to vasopressin resistance, either primary, or secondary to other factors, e.g. actual water transport.

Keywords: lithium; vasopressin; polyuria; vasopressin receptor; vasopressin resistance


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Exp ToxicolHome page
R. Nciri, M. Allagui, C. Vincent, J. Murat, F. Croute, and A. El Feki
The effects of subchronic lithium administration in male Wistar mice on some biochemical parameters
Human and Experimental Toxicology, October 1, 2009; 28(10): 641 - 646.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
C. Livingstone and H. Rampes
Lithium: a review of its metabolic adverse effects
J Psychopharmacol, May 1, 2006; 20(3): 347 - 355.
[Abstract] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. A. Cadnapaphornchai, S. N. Summer, S. Falk, J. M. Thurman, M. A. Knepper, and R. W. Schrier
Effect of primary polydipsia on aquaporin and sodium transporter abundance
Am J Physiol Renal Physiol, November 1, 2003; 285(5): F965 - F971.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Tian, K. Sandberg, T. Murase, E. A. Baker, R. C. Speth, and J. G. Verbalis
Vasopressin V2 Receptor Binding Is Down-Regulated during Renal Escape from Vasopressin-Induced Antidiuresis
Endocrinology, January 1, 2000; 141(1): 307 - 314.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.